Skip to main content
. 2017 Jun 6;7:2829. doi: 10.1038/s41598-017-03097-x

Figure 3.

Figure 3

Drug release profiles of the formulations used in the experiments (n = 6): (A) comparison of commercial fast-release tablets and DOM-FSR tablets, (B) the influence of shell numbers, (C) the influence of infill percentages, and (D) comparison of the tablets with optimized parameters, tablets used for pharmacokinetic study, and tablets used for X-ray imaging.